Related Experiment Video
Updated: Apr 21, 2026

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
Novel antiseptic compound OPB-2045G shows potent bactericidal activity against methicillin-resistant Staphylococcus
Yasuhide Inoue1, Akifumi Hagi1, Takuya Nii1
1Naruto Research Institute, Research and Development Centre, Otsuka Pharmaceutical Factory Inc., Tokushima, Japan.
Abstract:
There is a need for new compounds to effectively treat methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE). The novel monobiguanide compound 1-(3,4-dichlorobenzyl)-5-octylbiguanide gluconate (OPB-2045G) has potential bactericidal activity. We sought to elucidate the potency of OPB-2045G bactericidal activity against MRSA and VRE compared to those of chlorhexidine digluconate (CHG) and povidone iodine (PVP-I). In vitro bactericidal activity was analysed using minimum bactericidal concentration (MBC) as the index. The in vivo bactericidal efficacy of OPB-2045G was examined by determining MRSA and VRE contamination of the normal dorsal skin of mice following removal of hair. After a 3 min treatment period, the MBC of OPB-2045G was lower than that of CHG and PVP-I against standard strains and clinical isolates. Additionally, in our in vivo mouse model, the in vivo bactericidal activity of 1.5 % OPB-2045G (a clinically relevant dose) was higher than that of 0.5 % CHG and equivalent to that of 10 % PVP-I against MRSA. Similarly, the in vivo bactericidal activity of OPB-2045G was higher than that of 0.5 % CHG and 10 % PVP-I against VRE. OPB-2045G showed more potent bactericidal activity against MRSA and VRE both in vitro and in vivo compared to CHG and PVP-I, indicating that OPB-2045G may provide better protection against health care-associated infections caused by these pathogens.
Insights
A new compound, OPB-2045G, demonstrates potent bactericidal activity against resistant bacteria like MRSA and VRE. This novel agent shows promise in combating health care-associated infections more effectively than current treatments.
Area of Science:
- Antimicrobial resistance
- Infectious diseases
- Pharmacology
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) pose significant threats in healthcare settings.
- Existing treatments are becoming less effective against these multidrug-resistant pathogens.
- Novel antimicrobial compounds are urgently needed to combat these infections.
Purpose of the Study:
- To evaluate the bactericidal potency of the novel monobiguanide compound OPB-2045G.
- To compare the efficacy of OPB-2045G against MRSA and VRE with established antiseptics: chlorhexidine digluconate (CHG) and povidone iodine (PVP-I).
Main Methods:
- In vitro analysis using minimum bactericidal concentration (MBC) to determine bactericidal activity.
- In vivo assessment of bactericidal efficacy in a mouse model of skin contamination with MRSA and VRE.
- Comparison of OPB-2045G at a clinically relevant dose (1.5%) against CHG (0.5%) and PVP-I (10%).
Main Results:
- OPB-2045G exhibited lower MBC values than CHG and PVP-I against MRSA and VRE strains.
- In vivo, OPB-2045G showed superior bactericidal activity against MRSA compared to CHG and was comparable to PVP-I.
- OPB-2045G demonstrated higher in vivo bactericidal activity against VRE than both CHG and PVP-I.
Conclusions:
- OPB-2045G displays potent in vitro and in vivo bactericidal activity against MRSA and VRE.
- The novel compound OPB-2045G offers a promising alternative for preventing and treating infections caused by these challenging pathogens.
- OPB-2045G may enhance protection against health care-associated infections.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Hand hygiene
Hand washing...
Antimicrobial Effectiveness
Chemical Agents for Microbial Control
Inhibitors of Gram-positive Cell Wall Synthesis
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...

